By Will Feuer
ViewRay, which makes the MRIdian radiation-therapy system, said it has filed for bankruptcy and plans to sell some or all of its assets.
The company said it has received a commitment of about $6 million in debtor-in-possession financing from MidCap Financial Services. That, along with existing liquidity, should be enough to support operations through the Chapter 11 process.
The company said Scott Drake has stepped down as chief executive officer, but will remain on the board. ViewRay named Paul Ziegler, who has been the chief commercial officer, as CEO.
"Despite the operating challenges, MRIdian has facilitated real societal value and remains critically important for a broad population of cancer patients, including those who were previously considered untreatable," Ziegler said.
The company earlier this year has cited challenges that include macroeconomic pressures and delayed installation schedules.
Shares of ViewRay fell almost 39% to 22 cents a share in premarket trading.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
July 17, 2023 07:16 ET (11:16 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。